| http://www.w3.org/ns/prov#value | - These compounds are tropomyosin-receptor kinase (Trk) inhibitors that may provide treatments for pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, and other disorders associated with abnormal activities of Trks.
|
